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The dorsal root ganglia (DRG, spinal ganglia) are a metameric series of structures that develop from neural crest cells
within the dorsal somitic mesoderm. A striking element of patterning within this meristic series is the disappearance
of the ®ve or six most rostral DRG early in the embryonic development of birds and mammals. The transient DRG
have been named ``Froriep's ganglia'' after their 19th century discoverer (reviewed in Lim et al., 1987). The ontogeny
of the longest surviving Froriep's ganglion of the chick embryo, DRG C2, has recently been examined in detail (Rosen
et al., 1996). At St. 18 (Embryonic Day (E)2.5/), the C2 DRG had the same shape and volume as permanent ganglia
C5 and C6. C2's development ®rst diverged from that of normal DRG at St. 19 (E30), when C2 was observed to be
half the size and shaped differently from its neighbors, and its peripheral nerve root began to degenerate. Both lower
proliferation and higher apoptosis rates contribute to the reduced size of C2 compared to normal DRG at St. 19±20.
One-third fewer C2 cells were found to be in S-phase when compared to neighboring ganglia, and apoptotic cells were
more than three times more abundant in C2 than in conventional DRG at this stage. Since growth factors modulate
both proliferation and apoptosis, we postulated that these molecules and/or their receptors might be responsible for
the difference in fate between C2 and C5. In order to begin to evaluate this hypothesis, we have now treated embryos
with nerve growth factor (NGF) in ovo. NGF treatments partially rescued C2, producing a 50% reduction in the normal
difference in size between C2 and C5 at St. 23. At least part of this rescue could be accounted for by increased levels
of proliferation in the NGF-treated C2 compared to those in control embryos. Proliferation in normal DRG C5 was
unaffected by NGF application. NGF treatment rescued DRG cells in both C2 and C5 from cell death. Staining of
pycnotic nuclei revealed that NGF dramatically reduced the death in the C2 ganglia. In addition to providing insight
into the early patterning of the DRG, our results shed new light on the best-studied neurotrophic factor, NGF. Our
®nding is the ®rst direct evidence for a role for NGF in control of DRG cell proliferation in vivo. q 1996 Academic Press, Inc.
INTRODUCTION amniotic species (reviewed in Lim et al., 1987). In humans
and mice, the ®rst permanent DRG is in cervical segment
2 (C2). In chicken embryos, C2 degenerates leaving C3 asThe meristic series of dorsal root ganglia (DRG) arise
the most rostral ``permanent'' DRG.from the migration of neural crest (NC) cells into the ros-
Much more recently, two studies were made of the ontog-tral half sclerotomes. A striking example of axial pat-
eny of the Frorieps ganglia, DRG C2, in chick embryos. Interning among the DRG is that the ganglia that develop
the ®rst study by Lim et al. (1987), it was con®rmed thatin the most rostral several somites (occipital and ®rst cer-
neural crest cells indeed migrated into the rostral halves ofvical) disappear early in embryogenesis. The initial de-
sclerotomes 2±6 and formed DRG that eventually degener-scription of these transient DRG in the ®rst sclerotomes
ated. The authors also found that neurons developed inwas attributed to Froriep by His nearly 100 years ago, and
some of these ganglia. Finally, from transplant experimentsthis observation was subsequently made in a number of
that they performed they concluded that the reason Fro-
riep's DRG do not survive is because ``cranial halves of the
occipital sclerotomes lack factors essential for DRG sur-1 To whom correspondence should be addressed. Fax: 972-3-535-
1824; e-mail: goldst@ashur.cc.biu.ac.il. vival.''
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Soon after this paper appeared, a study was made of the Charite et al., 1994; Alkema et al., 1995). Over the past 8
years or so, homologues of the Drosophila HOM complexontogeny of the nervous system of the junction between
genes have been found in animals from C. elegans to man.the head and the trunk (Kuratani et al., 1988) in the chick
The conclusion drawn from studies on pattern formationembryo. C2, the longest surviving Froriep's DRG, was ®rst
in the vertebral column and the hindbrain has been theobserved by neuro®lament staining at St. 20 (E3). At St. 23
formulation of a hypothesis that the expression of selectand 24 the C2 ganglion had a distinct peripheral root and
sets of Hox genes, a ``Hox code,'' is responsible for the deter-was located dorsally. The C2 ganglion was found to be dis-
mination of positional identity in vertebrates (McGinnistinctly present until at least St. 27. The ganglion was found
and Krumlauf, 1992), in analogy to their determining seg-in whole mount to have an unusual form, being relatively
mental identity in the ¯y. The fate of Froriep's ganglia hasspherical and dorsally located at later stages.
shown to be modi®able by changing Hox gene expression.The ®ndings of the above studies have recently been con-
For example, the mouse Froriep's ganglion C1 (®rst cervical®rmed and considerably extended (Rosen et al., 1996). HNK-
ganglion) was temporarily ``rescued'' by overexpression of1 antibody staining of whole embryos from St. 10 to 21,
the developmental patterning gene Hoxb-8 (Charite et al.,which delineates not only developing axons and nerve cells
1994) in transgenic mice. This was interpreted to be a ``pos-like neuro®lament antibodies, but also virtually all of the
terior transformation'' making the C2 ganglion more simi-neural crest (NC) precursors that migrate to form the anlage
lar to DRG in more caudal segments.of the DRG (Bronner-Fraser, 1986), generated the following
As a result of several years of intense study, an entire``life history'' of the ganglion that develops in C2. Neural
family of neurotrophic factors related to NGF have beencrest cells migrate from the neural tube at the level of the
isolated, the neurotrophins. Members of this family, includ-sixth somite at about the 13 somite stage, St. 11. By St. 14,
ing NGF, BDNF, and NT-3, have been shown to have multi-the NC cells are colonizing its rostral portion to form the
ple effects on chick DRG neurons and their precursors in-anlage of a DRG. Within a few hours at St. 18, a conven-
cluding enhancement of differentiation and proliferation,tional looking DRG forms in C2 that is indistinguishable
but all have in common the ability to support the survivalfrom the permanent DRG in the adjacent more caudal seg-
of some neurons that would otherwise undergo apoptosisments. The C2 ganglion begins to appear different from its
(reviewed in Davies, 1994). Other unrelated factors such as
neighbors at St. 19±20, when the ganglion takes up a rela- GDNF (Tomac et al., 1995) and SCF (c-kit ligand) (Carnahan
tively dorsal position in the sclerotome, and its peripheral et al., 1994) also have trophic effects on DRG cells. Different
root is distinctly thinner than that of C3. By St. 23, the root populations of these cells are apparently dependent on dif-
is much reduced in comparison to that of C3 and more ferent factors (i.e., Carrol et al., 1992). It is believed that
caudal DRG and is often missing altogether. some of these factors are provided to early DRG cells by
Computerized quanti®cation of serial camera lucida trac- the neural tube (Kalcheim and LeDouarin, 1986), but inter-
ings of the C2 (Frorieps) and C5, C6 (conventional trunk) action with the mesodermal microenvironment may be
ganglia revealed that at St. 18, all these DRG have the same necessary for their normal function (Brill et al., 1992). At
volume. However, as development progresses, the trunk later stages, survival factors are provided to sensory neurons
and C2 DRG continue to grow, but at different rates. At St. endings in the periphery, and their continued supply is nec-
19±20, two conventional DRG C5 and C6 were twice the essary for neuronal survival or, in other words, prevention
size of C2, but not different from one another. This differ- of apoptosis (reviewed in Oppenheim, 1991).
ence in size grows until St. 32, when C5 is almost three Some fundamental difference ®rst arises between C2 and
times the size of C2. By St. 36, C2 had completely degener- other DRG at St. 18±20 (Rosen et al., 1996). Since both cell
ated in 80% of embryos examined. division and death in the nervous system are modulated
Two important morphogenetic processes, proliferation by neurotrophic factors, it is possible that C2's demise is
and apoptosis, were found to participate in producing the brought about patterning of trophic factor/receptor expres-
early differential in growth between C2 and normal DRG. sion. In order to test this hypothesis, embryos were treated
in ovo with a well-known growth factor to see whether itFirst, using a double-label immunocytochemical procedure
could change the fate of the C2 ganglia. We present evidence(Avivi et al., 1994) more than 30% more cells were observed
that NGF application in ovo speci®cally modi®es the devel-to be in S-phase in normal DRG C5 than in C2 at St. 19±
opment of the C2 ganglion, at stages preceding those when20. The early DRG were then examined for apoptosis. It is
NGF was thought to have an effect on DRG cells. In addi-intuitively obvious that at some stage of development, large
tion, we show that NGF increases the proliferation of DRGamounts of apoptosis must produce the removal of C2 by
cells in C2, the ®rst report to our knowledge of a positiveSt. 36. However, it was not clear when this process might
effect on cell division of neuroectodermal derived cells bybegin. There was indeed a signi®cant amount of apoptosis
this well-studied factor.at St. 19±20 in C2, with only rare dead cells in C5 at this
stage. In addition, when apoptosis in normal cervical DRG
METHODSis at its peak at St. 28, even more massive apoptosis is
present in the C2 ganglia. Numbering of DRG
Studies of pattern formation in mice have recently spot- As described above, the DRG that form in the most rostral so-
mites degenerate early in embryogenesis, while the correspondinglighted the Frorieps ganglia (i.e., Kessel and Gruss, 1991;
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motor nerves remain. In the chick embryo, the ®rst four nerve embryos. The other half of the treated embryos had ratios of C5/
C2 volume averaging 1.7 or less, more than 20% lower than normal.roots coursing through somites make contributions to the hypo-
glossal nerve, and the ®fth is the ®rst cervical (C) spinal nerve (Lim Therefore, only these embryos were included in the quantitative
analyses. Qualitative examination of the C2 ganglia in the NGF-et al., 1987). As a result of this degeneration of the rostral DRG
therefore, the ®rst permanent DRG is associated with the third treated embryos showed that all C2 DRG that responded to NGF
quantitatively were also qualitatively different from C2 in controls.cervical (C) spinal nerve and is termed C3, and the longest-lived
(most caudal) Frorieps ganglion is C2. In normal embryos, C2 has a distinctive pro®le in cross section
and little or no peripheral nerve root (Fig. 2A). In all those embryosIn order to be sure that the C2 was correctly identi®ed in all
embryos (especially those which had received NGF and whose mor- in which NGF had an effect on C2/C5 volume ratio, the shape of
C2 was strikingly changed to be similar to that of C5 (Fig. 2C) andphology might be modi®ed) it was critical to ®nd a set of criteria
for determining the axial identity of DRG at the rostral end of the had substantial nerve roots. Many embryos that were rejected for
the quantitative analysis responded to NGF in this qualitative man-spinal cord. DRG were identi®ed as C2 if they ful®lled the follow-
ing criteria. First, they were continuous with the ``ganglion crest,'' ner, displaying a C5-like pro®le and a nerve root. The variability
in the quantitative responses can likely be attributed to the earlythe remnant of the more rostral Froriep's ganglia (Fig. 1). Second,
they were the last dorsal neural structure that was continuous with stage at which the NGF was administered. At St. 17±18, the net-
work of blood vessels is not yet well developed, and it is likelythe ganglion crest and obviously separated from the next most
caudal DRG, C3. Finally, the C2 ganglion is located opposite the that in some embryos, the NGF administered simply diffused away
from the site of application because of the mechanical handling ofjunction between the hindbrain and spinal cord. At this rostrocau-
dal level of the axis, the neural tube was consistently 20% larger in the egg. In addition, it is dif®cult to accurately stage embryos in
situ, and it is possible that degenerative changes may have alreadycross-sectional area than at cervical levels in all untreated embryos
(quantitative data not shown). This can also be seen clearly in both begun in C2 in some of the embryos.
For estimation of proliferation, embryos were given a pulse ofthe 3D reconstructions and photomicrographs in Figs. 1 and 2.
The C5 ganglion was used as an example of a control, normal bromodeoxyuridine (BrDU) before ®xation, triple stained with anti-
HNK-1 and anti-BrDU antibodies, and counterstained with hema-DRG in all experiments. This is because the development of this
speci®c DRG was examined in detail in a previous study of Froriep's toxylin. A total of 10 each of C2 and C5 DRG from ®ve embryos
that responded to NGF were compared to the same number of DRGganglia (Rosen et al., 1996) and other studies of pattern formation
among the early DRG (Goldstein et al., 1995). from ®ve carrier-treated controls. This technique is detailed in
Avivi et al. (1994). Three-dimensional reconstructions were made
from camera lucida drawings of HNK-1-stained embryos as de-
scribed previously (Goldstein et al., 1995; Rosen et al., 1996).Application of Growth Factors
Eggs were opened under sterile conditions, the shell membrane
was re¯ected, and NGF (2.5S, Chemicon) was delivered as 1-mg Quantitation of Apoptosis
pulse dissolved in 0.1% albumin in 50 ml of PBS. NGF was applied
Estimation of the numbers of dying cells was performed usingeither to the chorioallantoic membrane or into its cavity of em-
conventional nuclear staining in paraformaldehyde (PAF)-®xed em-bryos at St. 17±18, the stage immediately before the qualitative and
bryos, a technique that is sensitive enough to demonstratequantitative differences arise between C2 and other DRG (Rosen et
apoptosis in younger, St. 20 embryos (Rosen et al., 1996; Abbadieal., 1996). Control embryos received application of albumin/PBS.
et al., 1993). With PAF ®xation, chromatin was preserved as a ®neThe embryos were then returned to the incubator, and a second,
meshwork in normal cells, resulting in the easy distinction ofidentical dose was administered the next day, at approximately St.
small, densely (or brightly) stained pyknotic nuclei. These in turn21. In a few experiments 5 mg per dose was used, but this was
were easily distinguished from the larger erythrocytes with theirnot any more effective in rescuing the C2 DRG (data not shown).
less dense nuclei and from mitotic ®gures. In the current studyEmbryos were sacri®ced at St. 23 and then ®xed in Bouin's ®xative
either Hoechst and hematoxylin nuclear staining combined withfor proliferation studies and 4% paraformaldehyde in PBS for
HNK-1 immunostaining (rhodamine) or fast-green, respectively, toapoptosis studies. Embryos were then embedded in paraf®n and
delineate the ganglia was used (Fig. 4). As was the case in theserially sectioned.
proliferation studies, 50% of embryos that were treated with NGF
responded with increased size of C2. A separate set of 10 each of
C2 and C5 DRG from ®ve NGF and ®ve control embryos wereDetermination of Volumes, Estimation of
used for the analysis of cell death.Proliferation, and 3D Reconstructions
TUNEL staining labels dying cells that have begun to enter
apoptosis, before they display the typical nuclear morphology ofIn order to determine the volumes of the C2 and normal ganglia,
camera lucida drawings were made of DRG in each of the serial this type of cell death (Gavrieli et al., 1992). We were unable to
produce consistent, homogeneous staining of complete sets of se-sections and measured with a digitizer attached to a PC (Goldstein,
1993; Gvirtsman et al., 1992; Goldstein et al., 1990). The DRG rial sections necessary for quantitative analysis using this tech-
nique. However, since we were interested in the ratio of dying cellswere delineated by staining with the HNK-1 antibody (Goldstein,
1993). In normal embryos examined in a previous study, and in the between different DRG and not their absolute numbers, our use of
the less sensitive technique of pycnotic nuclear morphology wascarrier-treated embryos in this study, the volume of C2 was about
half of that of C5 (Rosen et al., 1996). suf®cient.
In all ®gures depicting volume measurements and cell counts,NGF-treated embryos exhibited a bimodal distribution of results
with respect to this volume ratio of C2/C5. In exactly half of the the error bars represent the standard error of the mean (SEM). The
statistical signi®cance between groups of DRG was determinedembryos (10 of 20), C2's volume was similar to that of controls, and
the ratio C2/C5 was very similar to the average value for control with Student's t test.
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FIG. 1. 3D reconstructions of the nervous system at the junction between the brain and the spinal cord in PBS- (A and B) and NGF-
treated (C and D) embryos at St. 23. In control embryos, the C2 ganglion is small and dorsally located (see also Fig. 2). After NGF treatment,
the ganglion is shaped more like neighboring, conventional ganglion C3, and a root connecting it to the spinal nerve remains. Note that
in both normal and control embryos, the neural tube is larger at the C2 level. This is because this is still the medulla; the spinal cord
only begins at the level of ganglion C3, the ®rst permanent DRG (this is also evident in the photomicrographs in Fig. 2). In addition, C2
in both reconstructions is continuous with the remnant of C1, but separate from C3. The neural tube is depicted in blue, the ventral
roots and spinal nerves in green, and the DRG in yellow.
section than normal DRG (Figs. 1A and 1B). This can alsoRESULTS
be seen in the photomicrographs of cross sections through
C2 and C5 in Figs. 2A and 2B. As described under Methods,The C2 Ganglion at St. 23
C2 is continuous with the remnants of the more rostral DRG
In order to understand the effects of NGF on C2's develop- that have already degenerated and is separate from the ®rst
ment, a brief comparison of this ganglion to that of a typical permanent DRG, C3. The differences between C2 and nor-
cervical DRG C5 at St. 23 in normal chick embryos is pre- mal ganglia were also quantitative. At St. 23, the C2 ganglion
sented. Three-dimensional reconstruction of the neural tube occupied about one-half the volume of conventional DRG
and dorsal neural structures from C1 to C5 revealed that the C5 (Fig. 3) (n  10 each C2 and C5 DRG from ®ve embryos,
shape of C2 was quite different at St. 23. Throughout virtu- P  .0001). In contrast, C6 was virtually the same size as
C5 at this stage (data from Rosen et al., 1996).ally its entire rostrocaudal extent, C2 was smaller in cross
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FIG. 4. Photomicrographs of sections used for proliferation (A) and cell death (B±F ) studies. In A, the nuclei of cells that are in S-phase
are stained brown, the nuclei of cells that are not in S-phase are blue (arrows). The open arrow points to a mitosis in the neural tube
(NT). The ganglia (DRG) and neural tube are stained pink. Bar, 25 mm. Abbreviation: C, neural canal. In B, a section through DRG C2 in
a PBS-treated embryo is shown. Apoptotic nuclei are visible even at this low magni®cation (arrows). The pycnotic nucleus adjacent to
the upper arrow in B is seen at higher magni®cation in C. An open arrow points to a mitosis in D, which is easily distinguished from the
nearby pycnotic nucleus (arrowhead). Bright green cytoplasm and light staining nuclei are characteristic of erythrocytes in these prepara-
tions, and an example is shown adjacent to the open arrow in E. Nucleoli are not easily discerned in normal nuclei because the paraformalde-
hyde ®xation leaves the chromatin a ®ne meshwork. Fast green stains the cytoplasm of most apoptotic cells strongly. F shows several
dying motoneurons in the abortive cervical column of Terni (Oppenheim et al., 1982) in the neural tube of an NGF-treated embryo. Bars
in A and B, 25 mm; bar in F, 10 mm; C±F are the same magni®cation.
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FIG. 2. Photomicrographs of cross sections of C2 and C5 where they reach their maximal cross-sectional area in PBS-treated (A, B) and
NGF-treated (C, D) embryos. Sections were stained with the HNK-1 antibody to delineated the nervous system. In carrier-treated (and
untreated, Rosen et al., 1996) embryos, C2 is dorsally located and rounded in cross section. In most of these control embryos there is no
connecting root between C2 and the ventral root. After NGF treatment the ganglion appears more elongated, and a substantial sensory
root (SR) is present. For comparison, cross sections through C5 in the same embryos are shown in (C and D). Bar, 85 mm. Abbreviations:
SR, sensory root. VR, ventral (motor) root. NT, neural tube.
In Ovo Application of NGF Rescues the Froriep's 23 was more than twice the volume on average of C2, and
NGF treatment reduced this par by 50% (Fig. 3). In otherGanglion
words, NGF ``rescued'' about 50% of the C2 DRG in terms
It has recently been shown that the qualitative and quan- of volume. This increase in size of C2 caused by administra-
titative differences between C2 and C5 appeared at St. 19± tion of NGF was signi®cant (n  10 each C2 and C5 DRG
20 (see above). Growth factors are molecules known to in each experimental group, P  0.001). The C5 DRG in
modulate the two cellular processes that differed between NGF-treated embryos were slightly larger on the average
C2 and normal DRG, division and apoptosis. Therefore, an than those in the controls, but this difference was not sig-
attempt was made to reverse this process of degeneration ni®cant. There was also an increased number of cells in the
or ``rescue'' the C2 DRG by direct application of NGF to C2 ganglia as a result of NGF treatment. On the average
the embryo in ovo. there were 2592 { 131 cells in C5 and 1362 { 128 cells in
Application of 1 mg of NGF at St. 17±18 and again at St. C2 in PBS-treated embryos at St. 23. NGF treatment in-
21 had a profound effect on the St. 23 C2 DRG cells. In creased the number of cells in C2 by almost 25% to 1657
{ 108, while leaving the number of cells in C5 virtuallyuntreated and carrier-treated controls, the C5 DRG at St.
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proliferation, the proportion of DRG cells in S-phase was
determined (i.e., McMillan-Carr and Simpson, 1978; Ockel
et al., 1996). A double-immunocytochemical technique of
BrDU incorporation coupled with HNK-1 immunocyto-
chemistry for delineating the early ganglia was used (Avivi
et al., 1994; Goldstein et al., 1995). Photomicrographs of a
cross section of a St. 23 DRG stained in this manner is
shown in Fig. 4A.
In carrier-treated controls, the percentage of cells in S-
phase, or proliferation index (PI, McMillan-Carr and Simp-
son, 1978), in C5 at St. 23 was 34.7 { 1.4%. This value is
in agreement with that obtained in an earlier study of
DRG cell PI in normal embryos at St. 23 using [3H]-
thymidine (Goldstein et al., 1990). The PI of cells in C2
was 25.9 { 0.9, about 25% less than that in C5 (n  10
DRG from ®ve embryos; P  .001). In NGF-treated em-
bryos by contrast, this measure of proliferation in was
almost equal in the C2 and C5 ganglia. 36.125 { 1.0% of
cells in C2 incorporated BrDU compared to 37.0 { 0.8%
FIG. 3. NGF treatment in ovo partially rescues the Froriep's gan- in C5 (Fig. 5). Statistical comparison of the virtually iden-
glion. Volumes of ganglia C2 (hatched bars) and C5 (open bars) in
tical PIs in C5 in NGF- and carrier-treated embryos re-normal (NOR), carrier-treated (PBS), and NGF-treated (NGF) em-
vealed that they were not signi®cantly different. There-bryos. In both normal and PBS-treated controls, C2 is about one-
fore, this effect of NGF on DRG cell proliferation washalf the volume of C5. NGF treatment reduces this size discrepancy
speci®c to cells in the C2 ganglia.to 25%, i.e., C2 is 75% the size of C2. n  10 normal (Rosen et
al., 1996), 14 NGF-treated, and 12 carrier-treated DRG. Error bars
represent SEM. Cellular Processes in C2 Modi®ed by NGF
II. Apoptosis
As discussed above, NGF is well known as a survival
factor for neurons. Therefore, the possibility that the exoge-
unchanged at 2557 { 191. The increase in cell number was
also signi®cant (P  .001).
In addition to quantitative effects, the NGF-treated C2
ganglion had an appearance more similar to that of normal
DRG C5, with a larger cross-sectional area in each sec-
tion, and an elongated shape. This can be seen in both
the 3D reconstructions of a normal and an NGF-treated
embryo in Fig. 1 and the photomicrographs in Fig. 2. An-
other striking effect of NGF was on the peripheral root
of sensory ®bers that connect the DRG to their corre-
sponding ventral roots to form mixed nerves. In normal
St. 23 embryos this root had all but degenerated in C2. In
contrast, it was present (to varying degrees) in all NGF-
treated embryos (Figs. 1 and 2).
Cellular Processes in C2 Modi®ed by NGF
I. Proliferation
The effect of NGF treatment on two cellular processes
that could contribute to differences in growth between C2
and C5, proliferation and apoptosis, were then examined.
Although NGF administration is known to have mitogenic
FIG. 5. NGF speci®cally increases the proliferation of cells ineffects on many types of cells, it is not generally thought
C2. In control (PBS) embryos, the percentage of cells incorporation
to contribute to the proliferation of DRG precursors (see BrDU after a 70-min pulse is 25% lower in C2 (hatched bars) than
Discussion). However, at St. 20 there is less proliferation in normal ganglion C5 (open bars). NGF treatment (NGF ) brings
in C2 than in conventional DRG (Rosen et al., 1996). There- the level of proliferation in C2 to normal levels, without modifying
fore, it is possible that part of the rescue of C2 NGF might division in C5. N  10 each PBS- and NGF-treated DRG. Error bars
represent SEM.be due to an effect on cell division. In order to estimate
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nous application of NGF also might have an effect on cell
death in the C2 DRG was investigated. An additional series
of embryos were treated in ovo with NGF using the same
protocol as described in the proliferation studies above.
Upon sacri®ce, these embryos were ®xed in paraformalde-
hyde and stained using the nuclear stains Hoechst or hema-
toxylin (Fig. 4). Although St. 23 is considered to be before
the onset of natural apoptosis in avian cervical DRG
(McMillan-Carr and Simpson, 1978; Hamburger et al., 1981)
we and others have previously shown that pycnotic nuclei
can be observed in DRG as early as St. 20, when using
this means of histological preparation (Rosen et al., 1996;
Abbadie et al., 1993). In that study, there were signi®cantly
more dying cells present at St. 20 in the C2 DRG than in
normal DRG C5.
In carrier-treated St. 23 embryos, the number of dead cells
per ganglion was about twice as great for C2 than C5. If one
FIG. 6. Cell death in NGF-treated C2. In control embryos (PBS),takes into account the larger volume of C5, the rate of cell
approximately four times as many cells were apoptotic in C2 than
death in C2 is even greater, 30 { 4.3 pycnotic cells/1006 in C5 ganglia. In NGF-treated embryos (NGF ), cell death was sig-
mm3 were counted in C2 compared to 7.1 { 1.3 1006 mm3 ni®cantly reduced in both C2 and C5 with respect to their respec-
in C5. tive controls. n  8 each NGF- and carrier-treated DRG. Values
NGF treatment signi®cantly reduced the numbers of pyc- are expressed as the number of dead cells per volume. Error bars
notic nuclei in both C5 and C2. In C2 the reduction was represent SEM.
75% (7.7 { 1.4) and in C5 50% (3.1 { 1.1) (Fig. 6). Both of
these reductions were statistically signi®cant (P  .001).
Pycnotic nuclei, although rarer, were as easily distinguished
in the NGF-treated as in normal embryos. Dying cells were sive apoptosis in these peripheral ganglia. This is because
NGF is generally viewed as a survival factor for differenti-frequently observed in the ventral neural tube at the C5
level of the axis in both PBS and NGF treated embryos ated neurons rather than a factor affecting precursors in
DRG. The earliest effect of NGF in vivo demonstrated(Fig. 4F). These cells were likely to be those of the cervical
column of Terni that begins to degenerate at about this previously was upon the primary sympathetic ganglia
(Oppenheim et al., 1982). NGF administered on E3 (St.stage (Oppenheim et al., 1982).
20) increased the size of these ganglia by about 20% when
measured at St. 24±25. In that study, no change was found
in pyknotic cells number after NGF treatment, and prolif-DISCUSSION
eration was not studied.
Most in vitro studies of the effects of NGF have alsoIn this study, we examined the effect of the best-charac-
terized neurotrophic factor, NGF, on the programmed de- concluded that it does not affect DRG cells until later in
development (Davies, 1994). Sensory neuron precursors ingeneration of the chick Froriep's ganglion C2. NGF signi®-
cantly reduced the large morphological and size difference culture are thought to be initially independent of growth
factors. They then develop a dependence on BDNF and NT-between C2 and the conventional cervical ganglion C5. This
rescue resulted from both an increase of proliferation and a 3, other members of the neurotrophin family. (The same is
true for the well-studied neural crest-derived, NGF-depen-reduction of apoptosis in NGF-treated C2, compared to this
ganglion in vehicle-treated controls. By contrast, NGF did dent trigeminal ganglion sensory neurons (Wright et al.,
1992)). However, several studies from Bernd's laboratorynot have any signi®cant effect on the size or shape of normal
DRG [although it reduced the very low levels of cell death suggest that this view may be overly simplistic. First, it was
observed that NGF could increase cell number of DRG cellsin C5 (see below)].
cultured from St. 23 quail DRG. In that study, it was not
determined whether this was a result of increased survivalEarly Effect of NGF in Vivo or proliferation (Speight et al., 1993). Other studies from
her and other's laboratories showed that NGF, as well asTo the best of our knowledge, our results are the earliest
demonstration of an effect of NGF on DRG cells in ovo. trkA (Zhang et al., 1994) and p75LNGFR (Hallbook et al., 1990;
Heuer et al., 1990) mRNA are present before the onset ofSeveral previous studies have evaluated the effect of NGF
administration on apoptosis in the DRG of the chick em- programmed cell death in the DRG at St. 24±25. These
observations provide a molecular basis for our observationsbryo (i.e., Oppenheim et al., 1982; Hamburger et al.,
1981). However, in those studies the embryonic period (see below).
In the neurotrophic theory, apoptosis results from insuf-examined was from St. 25± 36, during the period of mas-
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®cient survival factor retrogradely provided to the soma prevention of cycling precursors from undergoing their
terminal mitosis and withdrawing from the cell cycle.by retrograde transport from axon terminals (Oppenheim,
1991). The cell death that takes place in C2 at St. 20 (Rosen This latter possibility seems unlikely, however, because
NGF is known to stimulate differentiation and not toet al., 1996) or St. 23 is not likely to follow this classic
pattern. At St. 20, the somitic mesoderm has just begun to prevent it in several experimental systems (Green and
Tishler, 1976; Anderson and Axel, 1986).separate into sclerotome and dermomyotome. Axons are
just traversing the sclerotome at this time, a tissue that is DRG at the stages examined in this study contain neu-
rons, glia, and (primarily) their precursors. Preliminary re-not a target for either sensory or motor neurons. At the
stage examined in the current study, St. 23, axon bundles sults have revealed that at least some of the additional cells
that are generated/survive as the result of NGF treatmenthave reached the dermomyotome at cervical levels of the
axis, but very little branching and few nerve endings are are neurons. Daily administration of NGF for an additional
3 days led to a large increase in the size of the C2 ganglionobserved in the nascent myotome and dermatome (unpub-
lished observations). In addition, even by St. 23, only a small when embryos were examined at St. 28 (E6). These hypertro-
phied ganglia contained many more large neurons than C2portion of the cells in the DRG have passed their ®nal divi-
sion and differentiated into neurons (McMillan-Carr and DRG from untreated embryos at this stage. Moreover, in
carrier-treated and normal embryos at this stage of develop-Simpson, 1978), a prerequisite in these cells for growing
axons (unlike sympathetic neuroblasts that differentiate ment, C2 never had a root of ®bers connecting it with the
ventral root to form a normal spinal nerve. C2 in thesewhile still mitotic).
NGF-treated embryos had such a root, again suggesting an
increase in the number of neurons (in preparation).NGF and Proliferation NGF has been shown to stimulate proliferation of several
nonneuronal cell types including mast cells, chromaf®nOur results are the ®rst to demonstrate an in-vivo en-
hancement of proliferation of DRG cells by NGF, albeit cells, keratinocytes, and supporting cells in sympathetic
ganglia (references in Muller et al., 1994). Although NGFin an atypical ganglion. Increased proliferation was the
original mechanism proposed for NGF's increase of neu- is generally thought of as a survival/differentiation factor
for neuroepithelium-derived cells, there have been severalron number in chick DRG and sympathetic ganglia by
Levi-Montalcini. However, this hypothesis was subse- reports suggesting that NGF may be involved in the prolifer-
ation of neural precursors. In one study, injections of anti-quently shown to be incorrect, apparently the result of
inadequate morphometric techniques (for review see Ja- bodies to NGF or p75LNGFR into the CSF were shown to
reduce the incorporation of thymidine into precursors ofcobson, 1991). In normal ganglia NGF did not affect the
PI of DRG cells at St. 23. It is important to point out granule cells of the rat cerebellum (Muller et al., 1994).
These antibodies also prolonged the cell cycle of this popu-that the increase of PI observed in C2 only brought cell
division to the same level as that in normal DRG. This lation. From these results and complementary in vitro ex-
periments, the authors proposed that NGF is indeed in-suggests that locally supplied NGF may be generally in-
volved in control of early DRG cell proliferation, but the volved in the control of proliferation of these neurons. In a
study of the embryonic auditory system in vitro, it wasfactor or its receptors are normally present at saturating
levels. Continuous application of large quantities of neu- observed that NGF could increase the size of explanted otic
vesicles and cochlear±vestibular ganglia (Represa andtralizing anti-NGF antibodies from E3 to E11 has been
shown to reduce the numbers of chick DRG neurons in Bernd, 1989). Experiments using a somewhat indirect
method to distinguish between proliferation and survivalovo when embryos were examined at E11 (Rohrer et al.,
1988). It is possible that part of the antibody's effect was effects led to the conclusion that NGF was likely to be
controlling proliferation in this system as well. Theyto reduce proliferation, as well as cell survival. This could
be tested by evaluation of the PI in younger (E3± 4) em- pointed out that the NGF's effect could have been indirect,
acting through responsive support cells that in turn releasebryos that had received anti-NGF at early stages.
The increased PI in C2 strongly suggests that NGF's another factor producing neural proliferation. In another in
vitro study, the long-term treatment of brain stem cellseffect is on proliferation rather than upon survival of cy-
cling DRG precursors. This is because if only survival with NGF increased their proliferation (Cattaneo and
McKay, 1990). However, the NGF concentration was highwas enhanced, the absolute number of BrDU-labeled cells
would have increased, but not their percentage of the pop- in these experiments, and the effect of NGF was dependent
on the presence of a known mitogen, bFGF, so the relevanceulation (DiCicco-Bloom et al., 1993). (This argument
holds true assuming that the DRG contains a more-or- of these experiments to normal development of these cells
in the brain is unclear.less homogeneous population of precursors. NGF could
potentially selectively support the survival of a subpopu- An in vitro study of St. 23 quail DRG showed that NGF
increased by 30% the number of neurons after 24 hr inlation of cycling precursors, producing an increase in the
proportion of cells in S-phase.) The increased PI in C2 culture (Speight et al., 1993). This is in spite of the fact that
this stage precedes the innervation of peripheral tissues. Inresulting from NGF application could result from short-
ened cell cycle times (Muller et al., 1994) or from the that study, however, there was no attempt to discern be-
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tween survival and proliferative effects of NGF. Our prelim- been shown in several systems that NGF can induce the
expression of its receptors p75 and trkA (reviewed in Daviesinary observations of increased neural numbers in C2 in
long-term treated embryos differ from all the above studies, et al., 1995). It is possible that such a phenomenon could
contribute to the observed rescue of C2 by NGF. This istherefore, in that this is the ®rst case of the upregulation
of proliferation by NGF on neural precursors in vivo. especially possible in light of the fact that in the treatment
regimen used, the ®rst dose of NGF could induce receptors
that increase the response to the second dose. Another pos-
NGF Receptors sible complication is that the effect of NGF on the DRG
could be indirect, as pointed out by Repressa and BerndWhat are the possible mechanisms for our observed res-
cue of C2 by exogenous NGF? mRNAs for NGF, and its (1989). p75 receptors are found in a great variety of tissues,
and it is possible that one of these tissues could release ahigh-af®nity receptor trkA, are present in DRG from St. 23
(the earliest stage they can be dissected), as detected by RT± factor that in turn modulates DRG proliferation/apoptosis.
PCR (Zhang et al., 1994). The physiological effects of NGF
are thought to be primarily mediated by its high-af®nity
Early Cell Death in the DRG and Its Reduction byreceptor, trkA. However, trkA levels are apparently very
NGFlow at this stage, since they cannot be detected by in situ
hybridization, only RT±PCR. The physiological effect me- Numerous studies utilizing various techniques have
shown that NGF is a survival factor for DRG neurons. Indiated by trkA in DRG has been on survival of neurons, so
at this stage that precedes innervation and retrograde supply the chick, the programmed cell death period in the DRG
was shown to start at St. 25 (McMillan-Carr and Simpson,of NGF, it is not surprising that it is not highly expressed.
The low-af®nity receptor p75 is detectable from neural crest 1978; Hamburger et al., 1981). Using a somewhat more sen-
sitive technique, we and others have recently shown thatmigratory stages in the rat by immunocytochemistry (Yan
and Johnson, 1988) and in the chick by in situ hybridization apoptosis can be detected in the nascent DRG as early as
St. 20 (see Methods). Very low levels of cell death in normal(Hallbook et al., 1990; Heuer et al., 1990).
Since p75 is apparently expressed earlier in development DRG C5 were observed at this stage; in C2 by contrast,
there were more than four times as many pycnotic nuclei.than trkA, we speculate that p75 is at least partially respon-
sible for the effect observed on proliferation. Evidence from Using the same techniques as used in that study, it was
now found that at St. 23 there is slightly more death thanseveral other studies supports the conjecture that this recep-
tor pathway may indeed by involved in proliferation. First, at St. 20 in normal cervical DRG such as C5. At this stage
as well, the levels of apoptosis in C2 were again about fouras mentioned above, cerebellar granules cells proliferate less
when anti-p75 antibodies are administered intrathecally times greater than in C5. NGF treatment in ovo dramati-
cally reduces the levels of cell death in C2. NGF also re-(Muller et al., 1994). In addition, as mentioned above, the
levels of p75 are much higher than trkA at these early em- duces the low level of cell death present in C5 at St. 23, in
contrast to the lack of its effect on proliferation in thisbryonic stages. High levels of p75 are observed in the E3
chick facial nerve (Vazquez et al., 1994) and auditory system conventional DRG.
This reduction of cell death at such early stages by NGF(Represa and Bernd, 1989) when neural precursor prolifera-
tion is still taking place in these structures. is somewhat surprising. Death of DRG neurons from lack
of NGF is believed to be the result of unsuccessful competi-If this hypothesis is correct, one would expect to ®nd
differential expression of NGF and or p75 in normal em- tion for trophic factors in the periphery. The time course
of innervation of the neck region of the chick has not beenbryos between the C2 and neighboring segments at stages
17±18 and 21 when we apply NGF. The distribution of carefully studied, but the slightly more caudal DRG in-
nervating the wings only begins around St. 25. Examinationeither of these molecules at the segmental level in the chick
embryo has not been reported to date. We are now per- of sections of embryos stained with HNK or b-tubulin anti-
bodies to reveal axons showed that C5's nerves had justforming in situ hybridizations and immunocytochemistry
to investigate this issue. Precedents have been described for reached the myotome and dermis at St. 23 stage (data not
shown). Even more strikingly, there was a great deal of cellaxial level-speci®c effects and distributions of neurotrophic
factors in development. For example, it was found that mo- death in C2 at St. 20, when very few neurons have differenti-
ated in the DRG (McMillan-Carr and Simpson, 1978), andtoneurons in culture from wing levels of the neuraxis were
more sensitive to NT-3 and BDNF than those from the level the somite had just begun to differentiate into its compo-
nent parts. Our observations are of St. 23 embryos that re-of the axis innervating the legs. In other experiments, it
was observed that DRG cells from limb-innervating levels ceived NGF at St. 17±18 and 20 and are therefore likely
to precede the stage when the targets of cervical DRG areof the neuraxis expressed higher levels of trkC (Mettling et
al., 1993). This is likely due to the increased proportion of actually innervated. This would suggest that if NGF is in-
deed required for survival of some precursors in the earlyNT-3-responsive muscle±sensory neurons at these levels
(Hory-Lee et al., 1993). DRG, the source of the factor is local. NGF mRNA has been
shown to be present in the DRG itself (Zhang et al., 1994)Several known characteristics of NGF actions potentially
complicate the interpretation of our results. First, it has and those tissues that surround it: the neural tube (Yip and
Copyright q 1996 by Academic Press, Inc. All rights of reproduction in any form reserved.
AID DB 8285 / 6x10$$$323 08-01-96 02:05:29 dba AP: Dev Bio
61NGF Rescues Froriep's Ganglia
21-derived cell lines that produce basic ®broblast growth factor,Johnson, 1984; Maisonpierre et al., 1990; Elkabes et al.,
but not parental BHK-21 cells, initiate neuronal differentiation1994), and the somite (Wheeler and Bothwell, 1992; Elkabes
of neural crest cells. Development 115, 1059±1069.et al., 1994) in early chick and rodent embryos.
Bronner-Fraser, M. E. (1986). Analysis of the early stages of trunk
neural crest migration in avian embryos using a monoclonal anti-
body HNK-1. Dev. Biol. 115, 44 ±55.Hox Genes and Neurotrophins
Carnahan, J. F., Patel, D. R., and Miller, J. A. (1994). Stem cell factor
How is difference in fate between C2 and normal DRG is a neurotrophic factor for neural crest-derived chick sensory
established? It has recently been shown that modi®ed ex- neurons. J. Neurosci. 14, 1433±1440.
pression of Hox genes in transgenic mice can modulate the Carrol, S. L., Silos-Santiago, I., Frese, S. E., Ruit, K. G., Milbrandt,
fate of Froriep's ganglia. For example, ectopic rostral expres- J., and Snider, W. D. (1992). Dorsal root ganglion neurons express-
ing trk are selectively sensitive to NGF deprivation in utero.sion of a normally caudally expressed Hox b-8 lead to the
Neuron 9, 779±788.prolonged survival of the murine Froriep's ganglia (Charite
Cattaneo, E., and McKay, R. (1990). Proliferation and differentiationet al., 1994). It would therefore seem reasonable to suggest
of neuronal stem cells regulated by nerve growth factor. Naturethat the Hox code (McGinnis and Krumlauf, 1992) of some
347, 762±765.tissue(s) at the most rostral spinal levels differs from that
Charite, J., deGraff, W., Shen, S., and Deschamps, J. (1994). Ectopicat more caudal axial levels. We therefore postulate that pat-
expression of Hoxb-8 causes duplication of the ZPA in the fore-
terned expression of Hox genes modulates proliferation and limb and homeotic transformation of axial structures. Cell 78,
cell death in the C2 DRG, producing its unusual develop- 589±601.
mental plan. The regulation of these cellular processes may Davies, A. M. (1994). The role of neurotrophins in the developing
be effected, at least in part, via NGF/p75. Our results are nervous system. J. Neurobiol. 25, 1334±1348.
therefore signi®cant in that they may provide insight into Davies, A. M., Wyatt, S., Nishimura, M., and Phillips, H. (1995).
NGF receptor expression in sensory neurons develops normallyhow Hox genes control morphogenesis at the level of their
in embryos lacking NGF. Dev. Biol. 171, 434±438.target genes. This is one aspect of Hox gene research that
DiCicco-Bloom, E. M., Friedman, W. J., and Black, I. B. (1993).to date has proved quite intractable. Further study of this
NT-3 stimulates sympathetic neuroblast proliferation by pro-experimental system may provide important information
moting precursor survival. Neuron 11, 1101±1111.mechanistically linking Hox genes to the morphogenetic
Elkabes, S., Dreyfus, C. F., Schaar, D. G., and Black, I. B. (1994).processes of apoptosis and proliferation.
Embryonic sensory development: local expression of neuro-
trophin-3 and target expression of nerve growth factor. J. Comp.
Neurol. 341, 204±213.
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